Progyny Inc logo

PGNY - Progyny Inc Share Price

$47.5 1.7  3.8%

Last Trade - 09/04/21

Large Cap
Market Cap £3.02bn
Enterprise Value £2.94bn
Revenue £251.6m
Position in Universe 1569th / 6827
Unlock PGNY Revenue
Relative Strength (%)
1m -0.78%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 48.6 105.4 229.7 344.9 535.3 770.5 +92.2%
-36.9 +52.7
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ProgynyInc revenues increased 50% to $344.9M. Net income totaled$46.5M vs. loss of $8.6M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net Income reflectsConvertible preferred stock warrant valu decrease from$18.2M (expense) to $0K, Costs Associated with IPOs &Mergers decrease of 63% to $900K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


PGNY Revenue Unlock PGNY Revenue

Net Income

PGNY Net Income Unlock PGNY Revenue

Normalised EPS

PGNY Normalised EPS Unlock PGNY Revenue

PE Ratio Range

PGNY PE Ratio Range Unlock PGNY Revenue

Dividend Yield Range

PGNY Dividend Yield Range Unlock PGNY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PGNY EPS Forecasts Unlock PGNY Revenue
Profile Summary

Progyny, Inc. is a fertility benefits management company specializing in fertility and family building benefits solutions in the United States. The Company operates in one segment that is providing fertility and pharmacy benefits solutions. The Company also offers a benefits plan for the doctors and members. In addition to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx. Progyny Rx provides its members with access to the medications needed during their fertility treatments.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 3, 2008
Public Since October 25, 2019
No. of Shareholders: 67
No. of Employees: 210
Sector Healthcare
Industry Healthcare Providers & Services
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 87,215,936
Free Float (0.0%)
Eligible for
PGNY Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PGNY
Upcoming Events for PGNY
Monday 10th May, 2021 Estimate
Q1 2021 Progyny Inc Earnings Release
Wednesday 2nd June, 2021 Estimate
Progyny Inc Annual Shareholders Meeting
Tuesday 3rd August, 2021 Estimate
Q2 2021 Progyny Inc Earnings Release
Frequently Asked Questions for Progyny Inc
What is the Progyny Inc share price?

As of 09/04/21, shares in Progyny Inc are trading at $47.5, giving the company a market capitalisation of £3.02bn. This share price information is delayed by 15 minutes.

How has the Progyny Inc share price performed this year?

Shares in Progyny Inc are currently trading at $47.5 and the price has moved by 0.124k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Progyny Inc price has moved by 50.81% over the past year.

What are the analyst and broker recommendations for Progyny Inc?

There are no analysts currently covering Progyny Inc.

When will Progyny Inc next release its financial results?

Progyny Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Progyny Inc dividend yield?

Progyny Inc does not currently pay a dividend.

Does Progyny Inc pay a dividend?

Progyny Inc does not currently pay a dividend.

When does Progyny Inc next pay dividends?

Progyny Inc does not currently pay a dividend.

How do I buy Progyny Inc shares?

To buy shares in Progyny Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Progyny Inc?

Shares in Progyny Inc are currently trading at $47.5, giving the company a market capitalisation of £3.02bn.

Where are Progyny Inc shares listed? Where are Progyny Inc shares listed?

Here are the trading details for Progyny Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: PGNY
What kind of share is Progyny Inc?

Based on an overall assessment of its quality, value and momentum, Progyny Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Progyny Inc share price forecast 2021?

Shares in Progyny Inc are currently priced at $47.5. At that level they are trading at 13.16% discount to the analyst consensus target price of 0.00.

Analysts covering Progyny Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.338 for the next financial year.

How can I tell whether the Progyny Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Progyny Inc. Over the past six months, the relative strength of its shares against the market has been 41.83%. At the current price of $47.5, shares in Progyny Inc are trading at 33.83% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Progyny Inc PE Ratio?

The Progyny Inc PE ratio based on its reported earnings over the past 12 months is 88.61. The shares are currently trading at $47.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Progyny Inc?

Progyny Inc's management team is headed by:

David Schlanger - CEO
Peter Anevski - PRE
Jennifer Bealer - EVP
Beth Seidenberg - CHM
Frederick Cohen - IND
Kevin Gordon - IND
Jeffrey Park - IND
Lisa Greenbaum - EVP
Mark Livingston - CFO
Malissia Clinton - DRC
Roger Holstein - DRC
Who are the major shareholders of Progyny Inc?

Here are the top five shareholders of Progyny Inc based on the size of their shareholding:

TPG Capital, L.P. Private Equity
Percentage owned: 16.88% (14.7m shares)
Kleiner, Perkins, Caufield & Byers Venture Capital
Percentage owned: 12.72% (11.1m shares)
Macquarie Investment Management Investment Advisor
Percentage owned: 6.18% (5.39m shares)
Delaware Smid Cap Growth Fund Mutual Fund
Percentage owned: 6% (5.24m shares)
Fred Alger Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 5.18% (4.52m shares)
Similar to PGNY
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.